Skip to NavigationSkip to content

Manufacturing and Production

International Clinical Researcher of the Year 2022

Optimization of design transfer from device development to final assembly

CPhI Discover 2021

First patient enrolled in melanoma study

Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) have announced the screening of the first patient with a resected stage II BRAF-mutant melanoma for the Phase III study COLUMBUS-AD.

35 common health conditions GPs will no longer issue a prescription for

The NHS has published a list of 35 conditions that no longer require a prescription from a GP. These include conjunctivitis, back pain, indigestion, and threadworms.

Patients are advised to go to their pharmacy or supermarket to identify suitable treatments.

This list is intended to encourage people to use over-the-counter medicines purchased out of their own money, enabling the health service to save money it currently spends on dealing with drugs and prescriptions for more minor medical problems.

131 confirmed cases of monkeypox reported in 19 countries

UK officials have warned that monkeypox could turn into a Europe-wide endemic if pets catch the virus. This could also make the virus a permanent resident of the UK. 57 cases have now been recorded in the country, with a total of 131 confirmed in 19 countries so far, and 106 further suspected cases.

Regeneron treatment fights ultra-rare form of high cholesterol in children

Regeneron has shared positive results from its Phase III trial of a candidate drug, for children with a rare, life-threatening condition characterised by high cholesterol.

The drug, Evekeeza (evinacumab), demonstrated success in treating elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease (ACVD).

Study launched to investigate COVID-19 vaccine in young immunocompromised

The UK’s largest kidney research charity has announced the launch of a study into the protection offered by COVID-19 vaccines for immunocompromised transplant patients between 12-17 years old. The study will be an extension of a study into how additional doses of COVID-19 vaccines protect immunocompromised adults.

The research project was launched in December of 2021, evaluating third doses in adult patients, and was supported by a coalition of funders including Kidney Research UK, The Medical Research Council, Blood Cancer UK, Vasculitis UK, and the Cystic Fibrosis Trust.

WHO delivers 20 ambulances to Ukraine

In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even the most damaged and inaccessible areas to the Ministry of Health of Ukraine.

MGC Pharma receives patent protection for epilepsy drug

MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed to combat hard-to-treat forms of epilepsy, according to Proactive Investors.

The Slovenian Intellectual Property Office has not provided sign-off for CannEpil, which uses a self-nano emulsifying technology to carry the company’s high CBD, low THC medicinal compound.

CannEpil is one of four products approved for use in the Republic of Ireland, and prescribed to 300-400 people both in the Republic and in Australia.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches